<span item_type="fundamental" item_id="d98f4977f3e882e1bf32d7275299ac1a" counter_id="ST/US/PRKR" env="prod"></span><span item_type="announcement" item_id="515739238595233153" env="prod"></span><p>EPS: As of FY2025 Q1, the actual value is USD -0.03.</p><p></p><h3>Net Loss</h3><p>ParkerVision reported a net loss of $3.8 million for the first quarter of 2025, compared to a net loss of $0.7 million for the third quarter of 2024.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/914139/000143774925016430/ex_764319.htm"></span></p><h3>Operating Expenses</h3><p>Total operating expenses for the first quarter of 2025 were $1.243 million, up from $773 thousand in the same period of 2024.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/914139/000143774925016430/ex_764319.htm"></span></p><h3>Cash Flow</h3><p>Net cash used in operating activities was - $1.827 million for the first quarter of 2025, compared to - $793 thousand for the same period in 2024.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/914139/000143774925016430/ex_764319.htm"></span></p><h3>Cash and Cash Equivalents</h3><p>The company ended the first quarter of 2025 with $3.3 million in cash and cash equivalents, down from $4.918 million at the end of December 2024.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/914139/000143774925016430/ex_764319.htm"></span></p><h3>Contingent Payment Obligations</h3><p>The change in fair value of contingent payment obligations resulted in a non-cash charge of $2.5 million for the first quarter of 2025.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/914139/000143774925016430/ex_764319.htm"></span></p><h3>Outlook</h3><p>ParkerVision anticipates several trial dates rescheduled in the Western District of Texas, with proceedings commencing in January 2026. The company is hopeful for expedient rulings from the Florida district court to schedule the Qualcomm case for trial.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/914139/000143774925016430/ex_764319.htm"></span></p>

ParkerVision, Inc. | 8-K: FY2025 Q1 EPS: USD -0.03